| abstract |
FIELD: medicine, oncology, pharmaceutics. SUBSTANCE: the innovation represents medicinal preparation efficient in cancer therapy and new medicinal preparation containing double-chain RNA as, for example, poly (I) • poly (C), concretely, and activator of cancer cell intracellular nuclease containing 2-O-(2- diethylaminoethyl)- carbamoil-1.3-O-dioleoilglycerol, and composition including a carrier obtained out of phospholipid as the main component, and poly (I) • poly (C) or poly (I) • poly (C) uncoupled along its foundations. EFFECT: higher efficiency of preparation in cancer therapy at its lower toxicity. 6 cl, 10 ex, 3 tbl, 2 fig |